The transcriptional programme of contact‐inhibition

Proliferation of non‐transformed cells is regulated by cell–cell contacts, which are referred to as contact‐inhibition. Vice versa, transformed cells are characterised by a loss of contact‐inhibition. Despite its generally accepted importance for cell‐cycle control, little is known about the intracellular signalling pathways involved in contact‐inhibition. Unravelling the molecular mechanisms of contact‐inhibition and its loss during tumourigenesis will be an important step towards the identification of novel target genes in tumour diagnosis and treatment. To better understand the underlying molecular mechanisms we identified the transcriptional programme of contact‐inhibition in NIH3T3 fibroblast using high‐density microarrays. Setting the cut off: ≥1.5‐fold, P ≤ 0.05, 853 genes and 73 cDNA sequences were differentially expressed in confluent compared to exponentially growing cultures. Importing these data into GenMAPP software revealed a comprehensive list of cell‐cycle regulatory genes mediating G0/G1 arrest, which was confirmed by RT‐PCR and Western blot. In a narrow analysis (cut off: ≥2‐fold, P ≤ 0.002), we found 110 transcripts to be differentially expressed representing 107 genes and 3 cDNA sequences involved, for example, in proliferation, signal transduction, transcriptional regulation, cell adhesion and communication. Interestingly, the majority of genes was upregulated indicating that contact‐inhibition is not a passive state, but actively induced. Furthermore, we confirmed differential expression of eight genes by semi‐quantitative RT‐PCR and identified the potential tumour suppressor transforming growth factor‐β (TGF‐β)‐1‐induced clone 22 (TSC‐22; tgfb1i4) as a novel protein to be induced in contact‐inhibited cells. J. Cell. Biochem. 110: 1234–1243, 2010. Published 2010 Wiley‐Liss, Inc.

[1]  D. Hershko,et al.  Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer , 2008, Cancer.

[2]  K. Chin,et al.  A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Guoying Liu,et al.  NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysis. , 2004, Bioinformatics.

[4]  T. Fujimori,et al.  Vesnarinone: a differentiation-inducing anti-cancer drug , 2003, Anti-cancer drugs.

[5]  R. Weinberg,et al.  G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment , 1991, Cell.

[6]  F. Oesch,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. , 2002, Toxicology and applied pharmacology.

[7]  D. Cobrinik Pocket proteins and cell cycle control , 2005, Oncogene.

[8]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[9]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[10]  J. den Hertog,et al.  Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. , 1999, The Journal of biological chemistry.

[11]  Terence P. Speed,et al.  A benchmark for Affymetrix GeneChip expression measures , 2004, Bioinform..

[12]  Keisuke Hitachi,et al.  TSC‐box is essential for the nuclear localization and antiproliferative effect of XTSC‐22 , 2007, Development, growth & differentiation.

[13]  T. Speed,et al.  Statistical issues in cDNA microarray data analysis. , 2003, Methods in molecular biology.

[14]  J. Rojas,et al.  Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38α Mitogen-Activated Protein Kinase via Sprouty2 Downregulation , 2009, Molecular and Cellular Biology.

[15]  P. Janik,et al.  Cellular quiescence induced by contact inhibition or serum withdrawal in C3H10T1/2 cells , 2005, Cell proliferation.

[16]  M. Fielden,et al.  A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  M. Heller,et al.  Differential expression of TGFβ‐stimulated clone 22 in normal prostate and prostate cancer , 2006 .

[18]  Q. Zeng,et al.  The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. , 2008, Cancer cell.

[19]  G. Zehetner,et al.  Downregulation of putative tumor suppressor gene TSC‐22 in human brain tumors , 2003, Journal of surgical oncology.

[20]  B. Gumbiner,et al.  Cell contact-dependent signaling. , 1996, Developmental biology.

[21]  F. Oesch,et al.  p16INK4 mediates contact-inhibition of growth , 1999, Oncogene.

[22]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[23]  F. Oesch,et al.  p38α MAPK is required for contact inhibition , 2005, Oncogene.

[24]  M. Barbacid,et al.  Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.

[25]  J. Sunshine,et al.  The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. , 1988, Science.

[26]  M. E. Ruaro,et al.  The growth arrest-specific gene, gas1, is involved in growth suppression , 1992, Cell.

[27]  K. Titani,et al.  Neural cell adhesion molecule mediates contact-dependent inhibition of growth of near-diploid mouse fibroblast cell line m5S/1M , 1991, The Journal of cell biology.

[28]  H. Yoshida,et al.  Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. , 1998, Cancer research.

[29]  M. Heller,et al.  Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer. , 2006, International journal of cancer.

[30]  L. Hengst,et al.  Skp2: caught in the Akt , 2009, Nature Cell Biology.

[31]  T. Fujimori,et al.  Expression and cellular localization of TSC-22 in normal salivary glands and salivary gland tumors: implications for tumor cell differentiation. , 2008, Oncology reports.

[32]  T. Willson,et al.  Peroxisome Proliferator-activated Receptor γ and Transforming Growth Factor-β Pathways Inhibit Intestinal Epithelial Cell Growth by Regulating Levels of TSC-22* , 2003, The Journal of Biological Chemistry.

[33]  T. Willson,et al.  Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. , 2003, The Journal of biological chemistry.

[34]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[35]  H. Tabuchi,et al.  Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factor , 2003, Oncogene.

[36]  M. Caligiuri,et al.  TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. , 2009, Blood.

[37]  B. Westermark,et al.  Inhibition of G1 cyclin-dependent kinase activity in cell density-dependent growth arrest in human fibroblasts. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  H. Yoshida,et al.  Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. , 1998, British Journal of Cancer.

[39]  E. Boitier,et al.  Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid study. , 2005, Chemical research in toxicology.

[40]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[41]  F. Oesch,et al.  Involvement of protein kinase Cδ in contact-dependent inhibition of growth in human and murine fibroblasts , 2001, Oncogene.

[42]  K. Nakayama,et al.  Regulation of the cell cycle by SCF-type ubiquitin ligases. , 2005, Seminars in cell & developmental biology.

[43]  H. Eagle,et al.  Growth Regulatory Effects of Cellular Interaction , 1967, Nature.

[44]  P. Baráth,et al.  The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. , 1999, Experimental cell research.

[45]  Steven C. Lawlor,et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.

[46]  M. Abercrombie,et al.  Contact inhibition and malignancy , 1979, Nature.

[47]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[48]  R. Assoian,et al.  A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle, and cancer , 2008, Cell cycle.

[49]  J. Collins,et al.  Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. , 2005, Carcinogenesis.

[50]  F. Oesch,et al.  Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts , 1997, Oncogene.

[51]  R. W. Holley,et al.  "Contact inhibition" of cell division in 3T3 cells. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Vladimir Petrovic,et al.  Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase , 2005, Molecular and Cellular Biology.